Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Competitor results !

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon May 20, 2021 12:05pm

163 Views

Post# 33237884

RE:RE:Competitor results !

Correct Cancerslayer and illustrates the degree to which presentation can matter.

Seems almost reverse psychology from TLT`s last Quarterly which included 3 optimally-treated patients whose 90-day results were yet to be received to half the headline interim CR% of those for whom results were actually available.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023